CVS Health Fiscal 2025 EPS Outlook Seen Lower on Health Care Benefits Segment, UBS Says
I'm PortAI, I can summarize articles.
CVS Health's fiscal 2025 EPS outlook has been lowered to $5.73 from $6.25 due to challenges in its health care benefits segment, according to UBS. The report anticipates a reduction of 500,000 at-risk members and a 10% drop in Medicare Advantage membership. UBS also cut its price target for CVS stock to $59 from $62 while maintaining a neutral rating. Despite concerns over regulatory risks and potential liabilities from opioid distribution lawsuits, CVS shares rose 0.3% in recent trading.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Trading View The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments